Fresenius, Xetra

Fresenius stock after-hours at EUR 44.75: plus 1.24 percent

Published on 09/30/2026 at 21:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock was last at EUR 44.75 on September 30, 2026, up 1.24 percent versus the prior close. The company has announced EUR 54 million in European production investments.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht
Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock was last at EUR 44.75 on Xetra on September 30, 2026, at 5:35 p.m. CEST. That was a gain of 1.24 percent versus the prior close of EUR 44.20.

European production expansion

In a September 25, 2026 investor release, Fresenius SE & Co. KGaA said it had opened a new intravenous-fluids production line in Kutno, Poland, and expanded production and warehouse infrastructure in Isola della Scala, Italy. The combined investments amounted to EUR 54 million, while Fresenius said it had invested more than EUR 1 billion in European manufacturing over the previous five years. The company said the projects are intended to increase local production capacity and strengthen healthcare supply chains. Fresenius

Quarterly reference

Fresenius’ investor-relations page reports second-quarter 2026 revenue of EUR 5,864 million, up 6 percent organically, and operating income of EUR 719 million, up 10 percent on a currency-adjusted basis. Core net income was EUR 470 million, up 14 percent on the same basis. Fresenius investor relations

Disclaimer...

en | boerse | 70206355 |